ATP6V1B2 and Intellectual disability: Pathogenic variants of ATP6V1B2 have been associated with various epileptogenic phenotypes, including intellectual disability (ID), seizures, and/or DOORS syndrome (deafness, onychodystrophy, osteodystrophy, ID, and seizures) [99,100,101,102].